BC
PTLA

Brinker Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Brinker Capital’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,952
Closed -$292K – 1000
2020
Q1 		$292K Sell
40,952
-2,422
-6% -$30.2K 0.01% 783
2019
Q4 		$1.04M Sell
43,374
-566
-1% -$15.6K 0.03% 492
2019
Q3 		$1.18M Buy
43,940
+12,620
+40% +$354K 0.04% 435
2019
Q2 		$850K Sell
31,320
-866
-3% -$27.2K 0.03% 534
2019
Q1 		$1.12M Buy
+32,186
New +$929K 0.04% 417

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.02B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $750M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return